Anna Gruszka

421 total citations
22 papers, 329 citations indexed

About

Anna Gruszka is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Anna Gruszka has authored 22 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Anna Gruszka's work include Pituitary Gland Disorders and Treatments (10 papers), Neuroendocrine Tumor Research Advances (6 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Anna Gruszka is often cited by papers focused on Pituitary Gland Disorders and Treatments (10 papers), Neuroendocrine Tumor Research Advances (6 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Anna Gruszka collaborates with scholars based in Poland, United States and Germany. Anna Gruszka's co-authors include Marek Pawlikowski, Maciej Radek, Michael D. Culler, Шломо Мелмед, Song-Guang Ren, Jesse Z. Dong, A Radek, Joerg S. Sachweh, Heike Schnoering and Jaime F. Vázquez-Jiménez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Endocrinology and Life Sciences.

In The Last Decade

Anna Gruszka

22 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Gruszka Poland 12 168 90 87 83 29 22 329
Monique De Vroede Netherlands 10 166 1.0× 73 0.8× 158 1.8× 61 0.7× 37 1.3× 17 361
Itaru Tsumanuma Japan 10 83 0.5× 49 0.5× 80 0.9× 65 0.8× 29 1.0× 18 359
R Paschke Germany 13 338 2.0× 131 1.5× 214 2.5× 76 0.9× 9 0.3× 25 596
Péter Gergics Hungary 14 257 1.5× 90 1.0× 209 2.4× 54 0.7× 33 1.1× 29 501
Angela Rogers United Kingdom 7 72 0.4× 57 0.6× 85 1.0× 35 0.4× 5 0.2× 11 224
Laurie A. Kane United States 8 247 1.5× 211 2.3× 66 0.8× 85 1.0× 42 1.4× 9 437
Elena Passeri Italy 12 137 0.8× 79 0.9× 129 1.5× 29 0.3× 22 0.8× 23 329
George Jeha United States 12 225 1.3× 179 2.0× 187 2.1× 36 0.4× 12 0.4× 23 551
Hanna Pisarek Poland 12 291 1.7× 86 1.0× 99 1.1× 172 2.1× 58 2.0× 51 468
Sarah Brickwood United Kingdom 6 127 0.8× 276 3.1× 323 3.7× 24 0.3× 6 0.2× 7 638

Countries citing papers authored by Anna Gruszka

Since Specialization
Citations

This map shows the geographic impact of Anna Gruszka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gruszka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gruszka more than expected).

Fields of papers citing papers by Anna Gruszka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gruszka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gruszka. The network helps show where Anna Gruszka may publish in the future.

Co-authorship network of co-authors of Anna Gruszka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gruszka. A scholar is included among the top collaborators of Anna Gruszka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gruszka. Anna Gruszka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatley, Richard J. D., Robert J. Slack, Anna Gruszka, et al.. (2019). The Design of Potent, Selective and Drug‐Like RGD αvβ1 Small‐Molecule Inhibitors Derived from non‐RGD α4β1 Antagonists. ChemMedChem. 14(14). 1315–1320. 6 indexed citations
2.
Gruszka, Anna, Joerg S. Sachweh, Heike Schnoering, et al.. (2017). Aortopexy offers surgical options for a variety of pathological tracheal conditions in paediatric patients. Interactive Cardiovascular and Thoracic Surgery. 25(4). 589–594. 10 indexed citations
3.
Gruszka, Anna. (2015). New Insight into the Mechanisms of the Anti-hyperglycemic Action of Metformin. British Journal of Medicine and Medical Research. 13(1). 1–9. 5 indexed citations
4.
Gruszka, Anna, Grzegorz Zieliński, & Maciej Radek. (2013). Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation. Journal of Clinical Neuroscience. 21(2). 340–342. 1 indexed citations
5.
6.
Gruszka, Anna, Michael D. Culler, & Шломо Мелмед. (2012). Somatostatin analogs and chimeric somatostatin–dopamine molecules differentially regulate human growth hormone and prolactin gene expression and secretion in vitro. Molecular and Cellular Endocrinology. 362(1-2). 104–109. 22 indexed citations
7.
Gruszka, Anna, et al.. (2012). Prevention of Postoperative Pericardial Adhesions With TachoSil. The Annals of Thoracic Surgery. 95(1). 183–188. 29 indexed citations
8.
Winczyk, Katarzyna, Maciej Radek, Anna Gruszka, Hanna Ławnicka, & Marek Pawlikowski. (2009). Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.. PubMed. 30(1). 107–10. 4 indexed citations
9.
Chesnokova, Vera, Svetlana Zonis, Anna Gruszka, et al.. (2009). Diminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence. Endocrinology. 150(6). 2603–2610. 25 indexed citations
10.
Gruszka, Anna, Song-Guang Ren, Jesse Z. Dong, Michael D. Culler, & Шломо Мелмед. (2007). Regulation of Growth Hormone and Prolactin Gene Expression and Secretion by Chimeric Somatostatin-Dopamine Molecules. Endocrinology. 148(12). 6107–6114. 40 indexed citations
11.
Gruszka, Anna, Maciej Radek, & Marek Pawlikowski. (2006). Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?. PubMed. 56(1). 14–8. 2 indexed citations
12.
Pawlikowski, Marek, Anna Gruszka, Ilona Kurnatowska, et al.. (2006). Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma.. SHILAP Revista de lepidopterología. 44(1). 37–41. 16 indexed citations
13.
Gruszka, Anna, Maciej Radek, Marek Pawlikowski, & H Stępień. (2005). Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas. Pituitary. 8(2). 163–168. 13 indexed citations
14.
15.
Pawlikowski, Marek, Anna Gruszka, & Maciej Radek. (2004). Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations.. SHILAP Revista de lepidopterología. 42(4). 245–7. 8 indexed citations
16.
Gruszka, Anna, Maciej Radek, & Marek Pawlikowski. (2004). The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma.. SHILAP Revista de lepidopterología. 42(1). 35–9. 10 indexed citations
17.
18.
Pawlikowski, Marek, et al.. (2002). The Antiproliferative Effects of Melatonin on Experimental Pituitary and Colonic Tumors. Advances in experimental medicine and biology. 369–372. 8 indexed citations
19.
Pawlikowski, Marek, et al.. (2001). Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors.. PubMed. 35(3). 139–42. 16 indexed citations
20.
Gruszka, Anna, Marek Pawlikowski, & Maciej Radek. (2001). Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.. PubMed. 22(5). 343–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique De Vroede Breakdown of academic impact, for papers by Itaru Tsumanuma Breakdown of academic impact, for papers by R Paschke Breakdown of academic impact, for papers by Péter Gergics Breakdown of academic impact, for papers by Angela Rogers Breakdown of academic impact, for papers by Laurie A. Kane Breakdown of academic impact, for papers by Elena Passeri Breakdown of academic impact, for papers by George Jeha Breakdown of academic impact, for papers by Hanna Pisarek Breakdown of academic impact, for papers by Sarah Brickwood
Rankless by CCL
2026